Dutch Beverage Stock News

SBM Offshore (ENXTAM:SBMO) has secured Front End Engineering and Design contracts from ExxonMobil Guyana Limited for the Longtail FPSO project. This initiates funding release and deploys its Fast4Ward hull program in Guyana. See our latest analysis for SBM Offshore. At a share price of €34.32, SBM Offshore has seen a 40.08% 90 day share price return and an 83.85% 1 year total shareholder return, suggesting recent momentum has been building as it secured the ExxonMobil FEED award and joined...

Fugro (ENXTAM:FUR) highlighted its dividend policy with an annual payout of €0.1500 per share, payable on 22 May 2026, with an ex-dividend date of 27 April and a record date of 28 April. See our latest analysis for Fugro. Fugro's €10.47 share price comes after a 22.89% 90 day share price return and 20.48% year to date share price return, while the 1 year total shareholder return is a decline of 15.49%. This suggests that recent momentum contrasts with weaker longer term results as investors...

CSG (ENXTAM:CSG) has just posted its FY 2025 first half numbers with total revenue of €2.8 billion and net income of €238.9 million, while trailing twelve month revenue stands at €5.2 billion against net income of €522.7 million and a reported 46.6% earnings growth over the past year. The company has seen revenue move from €1.6 billion in the first half of FY 2024 to €2.4 billion in the second half and then €2.8 billion in the first half of FY 2025, with net income shifting from €242.2...

Aegon (ENXTAM:AGN) has just released its FY 2025 numbers, reporting second half revenue of €2.9 billion, basic EPS of €0.24 and net income of €362 million, set against trailing twelve month EPS of €0.59 and net income of €927 million. The company has seen revenue move from €6.4 billion and EPS of €0.44 in the second half of 2024 to €6.7 billion and EPS of €0.36 in the first half of 2025. Over the same period, trailing twelve month revenue has shifted from €12.8 billion with EPS of €0.37 to...

Investors were disappointed with the weak earnings posted by The Magnum Ice Cream Company N.V. ( AMS:MICC ). Despite...

Why InPost’s latest earnings and auditor warning matter for shareholders InPost (ENXTAM:INPST) is in the spotlight after reporting 2025 results that pair higher sales with sharply lower profits, alongside an auditor warning about its ability to continue as a going concern. That combination, together with management’s guidance for further revenue growth in 2026, leaves you weighing a business that is still growing its parcel locker footprint against fresh questions about financial resilience...

Pharming Group (ENXTAM:PHARM) is back on investor radars after Japan’s Ministry of Health, Labour and Welfare approved Joenja for activated PI3K delta syndrome in patients aged 4 and older, including children 4 to 11. See our latest analysis for Pharming Group. The Joenja approval in Japan comes after a period where short term share price performance has been softer, with a 30 day share price return showing a decline of 1.21% and a year to date share price return showing a decline of 4.85%,...

On March 12, 2026, DSM-Firmenich AG announced a share repurchase program of up to €540 million, with €500 million earmarked for capital reduction and €40 million to satisfy share-based compensation, to be executed by a mandated bank and targeted for completion by the end of Q3 2026. This sizable buyback authorization signals the Board’s willingness to return cash to investors while tightening the share count, which can meaningfully influence ownership dilution from employee equity plans and...

Event context and recent share performance Exor (ENXTAM:EXO) has drawn investor attention after a period of weaker share performance, with the stock showing a 1-day return decline of 1.85% and a past month return decline of 13.31%. See our latest analysis for Exor. At the current share price of €63.5, the stock’s weaker short term share price returns, including a 30 day share price decline of 13.31% and a year to date share price decline of 12.95%, align with a 1 year total shareholder return...

Ahold Delhaize USA CEO JJ Fleeman is set to step down in June 2026. The company has not yet named a successor for its U.S. operations. The transition affects one of the largest markets for Koninklijke Ahold Delhaize (ENXTAM:AD). Koninklijke Ahold Delhaize (ENXTAM:AD), trading at €40.53, sits at the center of a meaningful leadership change in its U.S. business. The company has seen returns of 16.2% year to date and 22.7% over the past year, with a 47.6% gain over three years and 102.0% over...

Buyback announcement and what it could mean for DSM-Firmenich shares DSM-Firmenich (ENXTAM:DSFIR) has announced a share repurchase program of up to €540 million. Of this amount, €500 million is aimed at reducing issued capital and €40 million is reserved for share-based compensation commitments. See our latest analysis for DSM-Firmenich. At a share price of €58.12, DSM-Firmenich’s recent buyback announcement lands after a softer run, with a 30-day share price return of a 4% decline and a...

Avantium (ENXTAM:AVTX) has posted another loss for H1 2025, with revenue of €6.7 million, basic EPS of €1.08 loss, and net income loss of €9.4 million framing the latest set of numbers. Over recent halves the company has seen revenue move from €9.0 million in H1 2024 to €12.1 million in H2 2024, and EPS shift from a €1.75 loss in H1 2024 to a €1.69 loss in H2 2024, while trailing twelve month EPS sits at a €2.86 loss on €18.8 million of revenue. For investors, the key question now is whether...

OCI (ENXTAM:OCI) FY 2025 earnings snapshot OCI (ENXTAM:OCI) has opened FY 2025 with a mixed first half, reporting total revenue of US$566.9 million and a basic EPS loss of US$1.57, alongside earnings from discontinued operations of US$673.6 million and net income loss excluding extra items of US$330.6 million, against a share price of €3.48. Over recent periods the company has seen revenue move from US$509 million in 1H 2024 to US$566.9 million in 1H 2025. Basic EPS shifted from a loss of...

This article looks at whether CVC Capital Partners shares might be starting to look like value after a difficult period, by exploring what the current price could be implying about the company. The stock last closed at €11.32, with returns of a 4.5% decline over 7 days, an 11.8% decline over 30 days, a 19.3% decline year to date, and a 38.5% decline over the past year, which may have influenced how investors view both its potential and its risks. Recent coverage has examined how CVC Capital...

How Aalberts Stock Has Been Performing Recently Aalberts (ENXTAM:AALB) has moved lower in the very short term, with a 1 day decline of about 1% and a 7 day decline of about 1.4%, drawing fresh attention from investors. Over the past month the share price shows a decline of about 10%. Over the past 3 months it shows a gain of roughly 11%, offering a mixed picture for recent traders and for longer holding periods. See our latest analysis for Aalberts. With the share price at €31.42, Aalberts...

At Mobile World Congress in March 2026, Twilio announced a partnership with KPN Netherlands and Google to roll out nationwide Rich Communication Services (RCS) Business Messaging across all major Dutch mobile operators, with Android support at launch and broader device coverage expected in 2026. This collaboration places KPN at the core of the Netherlands’ business messaging infrastructure, enabling enterprises to use richer, measurable and verified communications within native messaging...

In February 2026, the Amsterdam District Court issued an interim judgment in Macedonian Thrace Brewery’s long-running damages case against Heineken and Athenian Brewery, accepting MTB’s expert model and indicating principal damages of at least €43.00 million, with total awards including interest expected to exceed €83.00 million once finalized. Around the same time, Heineken advanced its push into non-alcoholic beer with the launch of Heineken 0.0 Ultimate in select U.S. states, introducing...

If you are wondering whether Aalberts is fairly priced or offering value at its recent share price, this article will walk through what the numbers actually say rather than relying on headlines or hype. The stock last closed at €31.76, with a 7 day return of a 4.5% decline, a 30 day return of a 9.8% decline, a year to date return of 11.4%, and a 1 year return of a 2.5% decline. Taken together, this gives you a mixed picture of recent momentum and shifting risk appetite. Recent coverage has...

Sif Holding (ENXTAM:SIFG) has put fresh numbers on the table for FY 2025, with first half revenue of €258.2 million and a basic EPS loss of €0.91, setting a clear tone for where profitability currently stands. The company has seen revenue move from €230.98 million and EPS of €0.21 in the first half of 2024 to €198.0 million and an EPS loss of €0.36 in the second half of 2024, before landing at the latest half-year print. This keeps the focus firmly on how margins are holding up through this...

If you are wondering whether DSM-Firmenich at around €59 still reflects its true worth, you are not alone, and this article is built to help you assess what that price might really represent. The stock has been through a rough patch, with the share price down 14.6% over the last 30 days and 37.4% over the past year. It is up 2.9% over the past week and down 14.3% year to date. Recent coverage around DSM-Firmenich has focused on its position in the broader materials and specialty ingredients...

Basic-Fit (ENXTAM:BFIT) has wrapped up FY 2025 with second half revenue of €743.2 million and basic EPS of €0.34, alongside trailing 12 month revenue of €1.42 billion and basic EPS of €0.22. These figures frame the latest numbers in a broader earnings upswing. The company has seen revenue move from €630.44 million in the second half of 2024 to €743.2 million in the second half of 2025, while basic EPS shifted from €0.06 to €0.34 over the same periods. This sets up a story where higher sales...

Pharming Group (ENXTAM:PHARM) has wrapped up FY 2025 with fourth quarter revenue of US$106.5 million and basic EPS of US$0.008, while trailing twelve month figures stand at US$376.1 million in revenue and basic EPS of US$0.004. This frames a year where profitability on a full year basis edges into positive territory. The company has seen quarterly revenue move from US$92.7 million in Q4 2024 and US$74.8 million in Q3 2024 to US$106.5 million in Q4 2025. Over the same period, quarterly basic...

Envipco Holding (ENXTAM:ENVI) has reported its FY 2025 results with fourth quarter revenue of €23.8 million and a basic EPS loss of €0.03, while trailing twelve month revenue stands at €90.4 million with a full year basic EPS loss of €0.18. Over recent quarters the company has seen revenue move between €21.0 million and €23.8 million per quarter, while quarterly basic EPS losses have ranged from €0.03 to €0.07. This sets the scene for a story where strong reported revenue growth meets...

CVC Capital Partners (ENXTAM:CVC) has put up a punchy set of FY 2025 numbers, with first half revenue at €843.0 million and basic EPS of €0.54, set against trailing twelve month revenue of €1.85 billion and EPS of €1.11 that came with a very large year-on-year earnings increase and a net profit margin of 63.8% versus 14.4% the prior year. Over the past three reported halves, revenue has moved from €635.7 million with EPS of €0.05 in 1H 2024 to €926.2 million and EPS of €0.17 in 2H 2024,...